Headache, arthralgia, nasopharyngitis,upper respiratory infection, diarrhea and dizziness werereported. Caution recommended in patients with concomitant useof drugs that affect CYP2D6 and/or CYP3A substratemetabolism. Here, CYP2D6 is linked to respiratory tract infectious disorder.